Literature DB >> 8621884

An enzymatic method to determine receptor-mediated endocytosis.

L Cobern1, P Selvaraj.   

Abstract

Many studies have measured receptor-mediated endocytosis using radiolabeled ligands or antibodies. Upon ligation and cross-linking, the labeled ligand or antibody is endocytosed and the internalization of the radioisotope is assayed after stripping the uninternalized ligand from the cell membrane. This study reports on an enzymatic assay to measure receptor-mediated endocytosis and compares it with the radioactive method. The results show that receptor-mediated endocytosis measured using the peroxidase conjugated antibody is two fold higher than that measured with a radiolabeled antibody. Thus, approximately 38% endocytosis of CD3 is measured using an 125I-labeled antibody, whereas approximately 79% endocytosis is detected by peroxidase conjugated antibody method. Similar increases are also found with CD2 receptor-mediated endocytosis. Our study has demonstrated that the enzymatic method could be employed in determining receptor-mediated endocytosis. In addition to increased sensitivity, the enzymatic assay eliminates the use of radioactive materials.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8621884     DOI: 10.1016/0165-022x(95)00013-3

Source DB:  PubMed          Journal:  J Biochem Biophys Methods        ISSN: 0165-022X


  3 in total

1.  Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.

Authors:  Karen M Haas
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

2.  Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.

Authors:  Jaina M Patel; Vincent F Vartabedian; Min-Chul Kim; Sara He; Sang-Moo Kang; Periasamy Selvaraj
Journal:  Biotechnol Bioeng       Date:  2015-04-17       Impact factor: 4.530

3.  Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth.

Authors:  Jaina M Patel; Vincent F Vartabedian; Erica N Bozeman; Brianne E Caoyonan; Sanjay Srivatsan; Christopher D Pack; Paulami Dey; Martin J D'Souza; Lily Yang; Periasamy Selvaraj
Journal:  Biomaterials       Date:  2015-09-28       Impact factor: 12.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.